Schizoaffective Disorders Withdrawn Phase 3 Trials for Olanzapine (DB00334)

Also known as: Schizoaffective disorder / Schizophrenia schizoaffective / Schizoaffective psychosis / Schizo-affective type schizophrenia

IndicationStatusPhase
DBCOND0033299 (Schizoaffective Disorders)Withdrawn3
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT00440843Zyprexa and Task Engagement in SchizophreniaTreatment